arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2303.18005eess.IVcs.AIcs.LG

卵巢癌组织病理学中的人工智能:一项系统综述

Artificial Intelligence in Ovarian Cancer Histopathology: A Systematic Review

University of Leeds(利兹大学);St James’s University Hospital(圣詹姆斯大学医院)

Jack Breen, Katie Allen, Kieran Zucker, Pratik Adusumilli, Andy Scarsbrook, Geoff Hall, Nicolas M. Orsi, Nishant Ravikumar

AI总结:

该系统综述检索5个数据库截至2023年5月的相关研究,纳入45项研究共80个卵巢癌组织病理AI模型,发现所有模型偏倚风险高或不明确,尚无模型可落地临床,提出需完善报告规范与验证流程以推进转化。

摘要:

目的——刻画并评估已发表的、利用组织病理学数据评估人工智能(AI)方法用于卵巢癌诊断或预后的研究质量。方法——截至2023年5月19日,对PubMed、Scopus、Web of Science、CENTRAL和WHO-ICTRP数据库进行检索。纳入标准要求研究需评估基于组织病理学图像的AI在卵巢癌诊断或预后推断中的应用。采用PROBAST(预测模型偏倚风险评估工具)评估偏倚风险,将每个目标模型的相关信息制成表格并报告汇总统计量,遵循PRISMA 2020报告规范。结果——共检索到1573条记录,其中45项符合纳入标准。纳入研究包含80个目标模型,其中37个为诊断模型,22个为预后模型,21个为具有其他诊断相关结局的模型。模型构建使用了来自1-776名卵巢癌患者的1-1375张切片。模型结局包括治疗应答(11/80)、恶性状态(10/80)、染色量(9/80)和组织学亚型(7/80)。所有模型整体偏倚风险均为高或不明确,多数研究在分析环节偏倚风险较高,且研究的受试者与预测因子相关信息表述不清晰。研究普遍存在报告不充分、验证样本量有限的问题。结论——将AI应用于组织病理学图像以实现卵巢癌诊断或预后的研究仍较为有限,且尚无相关模型被证明可用于实际临床部署。保障临床转化的关键要点包括:更透明全面地报告数据来源与建模方法,以及通过交叉验证和外部验证改进定量性能评估。

英文摘要:

Purpose - To characterise and assess the quality of published research evaluating artificial intelligence (AI) methods for ovarian cancer diagnosis or prognosis using histopathology data. Methods - A search of PubMed, Scopus, Web of Science, CENTRAL, and WHO-ICTRP was conducted up to 19/05/2023. The inclusion criteria required that research evaluated AI on histopathology images for diagnostic or prognostic inferences in ovarian cancer. The risk of bias was assessed using PROBAST. Information about each model of interest was tabulated and summary statistics were reported. PRISMA 2020 reporting guidelines were followed. Results - 1573 records were identified, of which 45 were eligible for inclusion. There were 80 models of interest, including 37 diagnostic models, 22 prognostic models, and 21 models with other diagnostically relevant outcomes. Models were developed using 1-1375 slides from 1-776 ovarian cancer patients. Model outcomes included treatment response (11/80), malignancy status (10/80), stain quantity (9/80), and histological subtype (7/80). All models were found to be at high or unclear risk of bias overall, with most research having a high risk of bias in the analysis and a lack of clarity regarding participants and predictors in the study. Research frequently suffered from insufficient reporting and limited validation using small sample sizes. Conclusion - Limited research has been conducted on the application of AI to histopathology images for diagnostic or prognostic purposes in ovarian cancer, and none of the associated models have been demonstrated to be ready for real-world implementation. Key aspects to help ensure clinical translation include more transparent and comprehensive reporting of data provenance and modelling approaches, as well as improved quantitative performance evaluation using cross-validation and external validations.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑